Cargando…

Clinical Insights Into a New, Disposable Insulin Delivery Device

Detalles Bibliográficos
Autores principales:	Knutsen, P. Gaye, Voelker, Cheryl Q., Nikkel, Carla C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Departments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536649/ https://www.ncbi.nlm.nih.gov/pubmed/26300615 http://dx.doi.org/10.2337/diaspect.28.3.209

Ejemplares similares

The Clinical and Economic Impact of the V-Go(®) Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk
por: Lajara, Rosemarie, et al.
Publicado: (2016)

Regular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
por: Sutton, David, et al.
Publicado: (2016)

Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options
por: Sze, David, et al.
Publicado: (2018)

Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis
por: Sutton, David, et al.
Publicado: (2018)

Clinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go(®) Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective Analysis
por: Zeidan, Trisha, et al.
Publicado: (2020)

Use of V-Go(®) Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
por: Lajara, Rosemarie, et al.
Publicado: (2015)

Clinical Challenges With Concentrated Insulins: Setting the Record Straight
por: Brusko, Cynthia S.A., et al.
Publicado: (2017)

Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
por: Hundal, Ripu, et al.
Publicado: (2020)

Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
por: Cobry, Erin C., et al.
Publicado: (2019)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

Internal Experts Collaborate to Reduce Critical Hypoglycemia and Insulin Errors and Improve Insulin Administration Timing
por: Szelc, Kelley, et al.
Publicado: (2018)

Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
por: Schmidt, Sierra C., et al.
Publicado: (2016)

Insulin Resistance and Portal Vein Thrombosis
por: Aung, Nay Linn, et al.
Publicado: (2019)

Lessons in Care: Insights Into Recent Changes in the American Diabetes Association’s Clinical Practice Recommendations
por: Berg, Erika Gebel
Publicado: (2017)

Mysterious Hyperglycemia: Disease Versus Device
por: Inzucchi, Silvio E., et al.
Publicado: (2017)

Continuous Insulin Infusion: When, Where, and How?
por: Kelly, Janet L.
Publicado: (2014)

Insulin in America: A Right or a Privilege?
por: Hirsch, Irl B.
Publicado: (2016)

Cultural Differences and Considerations When Initiating Insulin
por: Rebolledo, Julio A., et al.
Publicado: (2016)

Good to Know: All About Insulin Resistance
Publicado: (2018)

Delayed Response to U-500 Regular Insulin
por: Davidson, Mayer B.
Publicado: (2018)

New Method of Inducing Premature Delivery
Publicado: (1854)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Commentary: Why Was Inhaled Insulin a Failure in the Market?
por: Oleck, Jacob, et al.
Publicado: (2016)

Extreme Insulin Resistance in Critically Ill Patient With Sepsis
por: Illuri, Vidhya D.S., et al.
Publicado: (2016)

A Case of Persistent Polyuria in an Insulin- Dependent Child With Diabetes
por: Mangaraj, Swayamsidha, et al.
Publicado: (2016)

Autoantibodies to Insulin and Dysglycemia in People With and Without Diabetes: An Underdiagnosed Association
por: Pavithran, Praveen Valiyaparambil, et al.
Publicado: (2016)

Disposable Device for Bacterial Vaginosis Detection
por: Avila-Huerta, Mariana D., et al.
Publicado: (2023)

Disposable circumcision suture device: clinical effect and patient satisfaction
por: Lv, Bo-Dong, et al.
Publicado: (2014)

Arsenal of microfluidic testing devices may combat COVID-19 pandemic
por: Berkenbrock, José Alvim, et al.
Publicado: (2020)

Prandial Insulin Dosing: How Long Does It Take to Go 80 Miles?
por: Mystkowski, Paul, et al.
Publicado: (2016)

InPen Smart Insulin Pen System: Product Review and User Experience
por: Gildon, Bradford W.
Publicado: (2018)

Five Simple Steps to Optimize Bolus Insulin Therapy in Type 2 Diabetes
por: Peters, Kyle R., et al.
Publicado: (2017)

Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control
por: Rhinehart, Andrew S.
Publicado: (2015)

Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
por: Sangave, Nikhil A., et al.
Publicado: (2019)

Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module
por: Lee, Hyunjae, et al.
Publicado: (2017)

Case Study: Use of GLP-1 Receptor Agonist in a Patient on Intensive Insulin Therapy
por: Wiley, Kenneth Calvin, et al.
Publicado: (2015)

Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens
por: Klonoff, David, et al.
Publicado: (2015)

A Comparison of Insulin Pen Devices and Disposable Plastic Syringes – Simplicity, Safety, Convenience and Cost Differences
por: Singh, Ripudaman, et al.
Publicado: (2018)

Development and Implementation of a U-500 Regular Insulin Program in a Federally Qualified Health Center
por: Shaw, Kathy F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bmh4q00qk3s1g8dilfjvksul9e